Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

40 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Worsening and newly diagnosed paraneoplastic syndromes following anti-PD-1 or anti-PD-L1 immunotherapies, a descriptive study.
Manson G, Maria ATJ, Poizeau F, Danlos FX, Kostine M, Brosseau S, Aspeslagh S, Du Rusquec P, Roger M, Pallix-Guyot M, Ruivard M, Dousset L, Grignou L, Psimaras D, Pluvy J, Quéré G, Grados F, Duval F, Bourdain F, Maigne G, Perrin J, Godbert B, Taifas BI, Forestier A, Voisin AL, Martin-Romano P, Baldini C, Marabelle A, Massard C, Honnorat J, Lambotte O, Michot JM. Manson G, et al. Among authors: dousset l. J Immunother Cancer. 2019 Dec 3;7(1):337. doi: 10.1186/s40425-019-0821-8. J Immunother Cancer. 2019. PMID: 31796119 Free PMC article.
Evolution of bone metastases in patients receiving at least three months of checkpoint inhibitors.
Gefard-Gontier E, Markich R, Zysman M, Veillon R, Daste A, Domblides C, Sionneau B, Gross-Goupil M, Lefort F, Prey S, Dutriaux C, Gerard E, Dousset L, Pham-Ledard A, Beylot-Barry M, Schaeverbeke T, Kostine M. Gefard-Gontier E, et al. Among authors: dousset l. Cancer Immunol Immunother. 2022 Nov;71(11):2609-2618. doi: 10.1007/s00262-022-03180-x. Epub 2022 Mar 19. Cancer Immunol Immunother. 2022. PMID: 35305123 Free PMC article.
Rheumatic disorders associated with immune checkpoint inhibitors in patients with cancer-clinical aspects and relationship with tumour response: a single-centre prospective cohort study.
Kostine M, Rouxel L, Barnetche T, Veillon R, Martin F, Dutriaux C, Dousset L, Pham-Ledard A, Prey S, Beylot-Barry M, Daste A, Gross-Goupil M, Lallier J, Ravaud A, Forcade E, Bannwarth B, Truchetet ME, Richez C, Mehsen N, Schaeverbeke T; FHU ACRONIM. Kostine M, et al. Among authors: dousset l. Ann Rheum Dis. 2018 Mar;77(3):393-398. doi: 10.1136/annrheumdis-2017-212257. Epub 2017 Nov 16. Ann Rheum Dis. 2018. PMID: 29146737
Positive Association Between Location of Melanoma, Ultraviolet Signature, Tumor Mutational Burden, and Response to Anti-PD-1 Therapy.
Dousset L, Poizeau F, Robert C, Mansard S, Mortier L, Caumont C, Routier É, Dupuy A, Rouanet J, Battistella M, Greliak A, Cappellen D, Galibert MD, Allayous C, Lespagnol A, Gerard É, Kerneuzet I, Roy S, Dutriaux C, Merlio JP, Vergier B, Schrock AB, Lee J, Ali SM, Kammerer-Jacquet SF, Lebbé C, Beylot-Barry M, Boussemart L. Dousset L, et al. JCO Precis Oncol. 2021 Dec 16;5:PO.21.00084. doi: 10.1200/PO.21.00084. eCollection 2021. JCO Precis Oncol. 2021. PMID: 34950838 Free PMC article.
Analysis of tumor response and clinical factors associated with vitiligo in patients receiving anti-programmed cell death-1 therapies for melanoma: A cross-sectional study.
Dousset L, Pacaud A, Barnetche T, Kostine M, Dutriaux C, Pham-Ledard A, Beylot-Barry M, Gérard E, Prey S, Andreu N, Boniface K, Seneschal J. Dousset L, et al. JAAD Int. 2021 Oct 19;5:112-120. doi: 10.1016/j.jdin.2021.09.002. eCollection 2021 Dec. JAAD Int. 2021. PMID: 34712997 Free PMC article.
Baseline co-medications may alter the anti-tumoural effect of checkpoint inhibitors as well as the risk of immune-related adverse events.
Kostine M, Mauric E, Tison A, Barnetche T, Barre A, Nikolski M, Rouxel L, Dutriaux C, Dousset L, Prey S, Beylot-Barry M, Seneschal J, Veillon R, Vergnenegre C, Daste A, Domblides C, Sionneau B, Gross-Goupil M, Ravaud A, Forcade E, Schaeverbeke T; FHU ACRONIM. Kostine M, et al. Among authors: dousset l. Eur J Cancer. 2021 Nov;157:474-484. doi: 10.1016/j.ejca.2021.08.036. Epub 2021 Oct 11. Eur J Cancer. 2021. PMID: 34649118 Free article.
[Impact on quality of life and autonomy of patients aged over 75 years treated with anti-PD-1 for metastatic melanoma: A single-centre prospective study].
Barailler H, Dousset L, Mertens C, Maurel A, Gérard E, Prey S, Dutriaux C, Beylot-Barry M, Pham-Ledard A. Barailler H, et al. Among authors: dousset l. Ann Dermatol Venereol. 2020 Nov;147(11):713-720. doi: 10.1016/j.annder.2020.07.012. Epub 2020 Sep 28. Ann Dermatol Venereol. 2020. PMID: 33004209 French.
40 results